Immune Effector Cellular Therapy Task Force

Purpose: The Immune Effector Cellular Therapy Task Force develops and promotes standards and accreditation for immune effector cellular therapy.

Current members of Immune Effector Cellular Therapy Task Force:

Position

Name

Organization

City

Country

Chair

Helen Heslop MD

Baylor College of Medicine, Stem Cell Transplant Program, Texas Children's Hospital and Houston Methodist Hospital

Houston

United States

Vice-Chair

Michael Lill MD

Blood and Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

Los Angeles

United States

Vice-Chair

Elizabeth J Shpall MD

M. D. Anderson Cord Blood Bank

Houston

United States

Member

Dr Carlos Bachier M.D.

Sarah Cannon Blood and Marrow Transplant Program

Nashville

United States

Member

Dr. Kevin Curran

Memorial Sloan-Kettering Cancer Center - Blood and Marrow Transplant Program

New York

United States

Member

David Maloney MD, PhD

Fred Hutchinson Cancer Research Center

Seattle

United States

Member

Marcela Maus MD, PhD

The Massachusetts General Hospital Bone Marrow Transplant Program

Boston

United States

Member

Philip McCarthy MD

Roswell Park Cancer Institute Corporation

Buffalo

United States

Member

Sarah Nikiforow

Dana Farber Cancer Institute / Cell Manipulation Core Facility

Boston

United States

Member

Jae Park MD

Memorial Sloan-Kettering Cancer Center, Leukemia Service

New York City

United States

Member

David Porter MD

Penn Medicine

Philadelphia

United States

Member

Phyllis Warkentin MD

Biologics Production Facility, Nebraska Medicine, The Nebraska Medical Center

Omaha

United States

Staff Liaison

Kara Wacker MBA, RAC

Foundation for the Accreditation of Cellular Therapy

Omaha

United States


Ask FACT

FAQ

As a Matter of FACT

FACT inspectors have free access to all FACT training and educational opportunities.